Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01077453 · ClinicalTrials.gov registry record · Phase 1
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
A Phase 1 study of Healthy, no Evidence of Disease and Lobular Breast Carcinoma in Situ, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 112
- Enrollment target
- 3
- Study locations
NCT01077453 is a Phase 1 study of Healthy, no Evidence of Disease and Lobular Breast Carcinoma in Situ that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 112 participants, below the 167-participant average among 11 other Healthy, no Evidence of Disease trials with a reported enrollment target (33% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT01077453, a Phase 1 study of Healthy, no Evidence of Disease and Lobular Breast Carcinoma in Situ, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 112 participants
- Enrollment target
- 3
- Study locations
Study Summary
This randomized phase I trial studies the side effects and the best dose of letrozole in preventing breast cancer in healthy postmenopausal women at high risk for breast cancer. Chemoprevention is the use of drugs to keep breast cancer from forming or coming back. The use of letrozole may keep cancer from forming in healthy postmenopausal women at high risk for breast cancer.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- DRUG letrozole
- OTHER quality-of-life assessment
Study Locations (3)
Arizona
- Arizona Cancer Center - Tucson - Tucson
- University of Arizona Health Sciences Center - Tucson
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2010-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01077453
The ClinicalTrials.gov registry entry for NCT01077453 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167-participant average among 11 other Healthy, no Evidence of Disease trials with a reported enrollment target (33% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Healthy, no Evidence of Disease appearing as the primary indexed condition, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT01077453 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Minnesota.
Frequently Asked Questions
What is clinical trial NCT01077453 about?
NCT01077453 is a clinical study titled "Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer". This randomized phase I trial studies the side effects and the best dose of letrozole in preventing breast cancer in healthy postmenopausal women at high risk for breast cancer. Chemoprevention is the use of drugs to keep breast cancer from forming or coming back. The use of letrozole may keep cance...
What is the current status of trial NCT01077453?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 112 participants. The study started on 2010-03.
What conditions does trial NCT01077453 study?
This clinical trial studies the following conditions: Healthy, no Evidence of Disease, Lobular Breast Carcinoma in Situ.
What interventions are being tested in trial NCT01077453?
The interventions under investigation include: laboratory biomarker analysis (OTHER), letrozole (DRUG), quality-of-life assessment (OTHER).
Who is sponsoring clinical trial NCT01077453?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01077453 being conducted?
This trial has 3 study locations across Arizona, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy, no Evidence of Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Studying Different Formulations of SR13668 in Healthy Volunteers
COMPLETED · Phase 1
-
Diindolylmethane in Healthy Volunteers
COMPLETED · Phase 1
-
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
COMPLETED · Phase 1
-
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
COMPLETED · Phase 1
-
Lycopene in Healthy Male Participants
COMPLETED · Phase 1
-
A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
COMPLETED · NA
Explore more on PlainTrial
Healthy, no Evidence of Disease
All registered trials for this condition
Lobular Breast Carcinoma in Situ
All registered trials for this condition
Arizona
All trials with a study site in Arizona
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.